Long-term follow-up of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation after primary induction failure
Miriam Mozaffari Jovein, Gabriele Ihorst, Jesús Duque-Afonso, Ralph Wäsch, Hartmut Bertz, Claudia Wehr, Justus Duyster, Robert Zeiser, Jürgen Finke, Florian Scherer · 2023
Read Long-term follow-up of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation after primary induction failure by Miriam Mozaffari Jovein, Gabriele Ihorst, Jesús Duque-Afonso, Ralph Wäsch, Hartmut Bertz, Claudia Wehr, Justus Duyster, Robert Zeiser, Jürgen Finke, Florian Scherer (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10710471.txt.
Description
Miriam Mozaffari Jovein and co-authors follow leukemia patients whose first drug round failed to clear the disease. For acute myeloid leukemia with primary induction failure, a donor stem cell transplant is the sole shot at cure. The team tracks how these high-risk patients fare over a full decade.
The study covers two hundred twenty patients who got transplants without ever reaching remission first. About a quarter stayed disease-free at five years, and about a fifth lived ten years. Relapse struck near half the group within ten years, and deaths without relapse took about a third. Bad gene marks at diagnosis, weak fitness at transplant, and long waits all tracked with worse odds. The authors urge fast donor searches, since a real share of patients still win long survival.
Catalog record
| CREATOR | Miriam Mozaffari Jovein, Gabriele Ihorst, Jesús Duque-Afonso, Ralph Wäsch, Hartmut Bertz, Claudia Wehr, Justus Duyster, Robert Zeiser, Jürgen Finke, Florian Scherer |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |